Top SMid Biotechnology Stocks: JPMorgan's Latest Picks for 2023

JPMorgan has identified several top SMid (small to mid-cap) biotechnology stocks for 2023. These stocks are noteworthy due to their potential for growth and investment opportunities in the biotechnology sector. Specific names or numbers have not been provided in the article, but JPMorgan's recommendations can influence market interest and trader decisions. Knowing which stocks are favored by analysts like JPMorgan may help ordinary investors make informed decisions in their portfolios.